Last reviewed · How we verify

NCT04491890

Cross-cultural Adaptation, Evaluation and Validation of Wang Qi's Constitution of TCM Questionnaire (For Old Person)

Completed Last updated 30 July 2020
What this trial tests

trial in Cross-cultural Adaptation, Evaluation and Validation Study of Wang Qi's Constitution in TCM Questionnaire (For Old Person) in 304 participants. Completed in 8 February 2020.

Timeline
31 July 2019
Primary endpoint
8 February 2020
8 February 2020

Quick facts

Lead sponsorHong Kong Baptist University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment304
Start date31 July 2019
Primary completion8 February 2020
Estimated completion8 February 2020
Sites1 location across China

Conditions studied

Sponsor

Hong Kong Baptist University

Who can join

65 and older, any sex, with Cross-cultural Adaptation, Evaluation and Validation Study of Wang Qi's Constitution in TCM Questionnaire (For Old Person). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-cultural adaptation, evaluation and validation study of Wang Qi's Constitution in TCM questionnaire (For Old Person) in Hong Kong to investigate the content validity, construct validity and reliability of the CTCMQ-C in Cantonese speaking Hong Kong Chinese elderly population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Validation of the Cantonese version of the Traditional Chinese Medicine (TCM) Body constitution Questionnaire in elderly people.
    Wong YL, Zhang J, Wu X, Wong SY, et al · · 2023 · cited 3× · PMID 37821975 · DOI 10.1186/s13020-023-00805-w

Verify or expand the search:

Other Hong Kong Baptist University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04491890.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing